Physician
Oncology
Dr. John J. Kavanagh, MD
|
|
Give Review
John Kavanagh works in the field of Oncology. He studied medicine at Medical University of South Carolina. John Kavanagh is also a published doctor. He has 57 publication published. The most recent publication is: Successful treatment of leptomeningeal relapse of epithelial ovarian cancer.
Publications
- Sustained complete response after maintenance therapy with topotecan and erlotinib for recurrent Cervical cancer with distant metastases.
- Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells.
- Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian Cancer cells through induction of apoptosis and downregulation of histon...
- Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum.
- Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian Cancer.
- Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithe...
- Nuclear cyclin B1 is overexpressed in low-malignant-potential ovarian tumors but not in epithelial ovarian Cancer.
- Recurrent low-grade serous Ovarian carcinoma is relatively chemoresistant.
- Uterine Neoplasms. Clinical Practice Guidelines in Oncology.
- Azacitidine enhances sensitivity of platinum-resistant ovarian Cancer cells to carboplatin through induction of apoptosis.
- Poor survival outcome with moderate and severe hypercalcemia in gynecologic malignancy patients.
- Diammine dicarboxylic acid platinum enhances cytotoxicity in platinum-resistant ovarian Cancer cells through induction of apoptosis and S-phase cell arrest.
- Chemotherapy for recurrent and metastatic Cervical cancer.
- Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade Cancer of the ovary or peritoneum.
- Intraperitoneal chemotherapy in the treatment of ovarian Cancer.
- Pegylated liposomal doxorubicin treatment in recurrent gynecologic Cancer patients with renal dysfunction.
- Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with Ovarian carcinoma.
- Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal Cancers.
- Ethics guidelines for research with the recently dead.
- Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian Cancer.
- Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials.
- First-line chemotherapy trial in advanced endometrial carcinoma.
- Proteomics in Cancer screening and management in gynecologic Cancer.
- An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast Malignancies.
- Novel agents in epithelial ovarian Cancer.
- Pilot study of Flt3 ligand comparing intraperitoneal with subcutaneous routes on hematologic and immunologic responses in patients with peritoneal carcinomatosis and m...
- Vulvar Langerhans cell histiocytosis: a case report and review of the literature.
- Intraperitoneal fluid neopterin, nitrate, and tryptophan after regional administration of interleukin-12.
- Establishment and characterization of Cancer cell cultures and xenografts derived from primary or metastatic Mullerian Cancers.
- Phase II trial of irinotecan in patients with metastatic epithelial ovarian Cancer or peritoneal Cancer.
- Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary Malignancies, and mesothelioma.
- Patient preferences regarding side effects of chemotherapy for ovarian Cancer: do they change over time?
- Docetaxel in the treatment of ovarian Cancer.
- Uterine Cancers.
- Cervical cancer guidelines. Clinical practice guidelines in oncology.
- Tamoxifen therapy of epithelial ovarian Cancer.
- Treatment of recurrent and metastatic Cervical cancer with cis-platin, doxorubicin, and cyclophosphamide.
- Successful treatment of leptomeningeal relapse of epithelial ovarian Cancer.
- Management of endometrial Cancer in Asia: consensus statement from the Asian Oncology Summit 2009.
- Associations with worry about dying and hopelessness in ambulatory ovarian Cancer patients.
- Adjuvant chemotherapy for endometrial Cancer.
- The associations between knowledge, CA125 preoccupation, and distress in women with epithelial ovarian Cancer.
- Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian Cancer.
- Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe throm...
- Increased expression of heat shock protein 70 in adherent ovarian Cancer and mesothelioma following treatment with manumycin, a farnesyl transferase inhibitor.
- A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal Cancer ...
- AntiCancer therapy targeting the apoptotic pathway.
- Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor.
- Insulin-like growth factor binding protein 2 promotes ovarian Cancer cell invasion.
- Ovarian Cancer, the coagulation pathway, and inflammation.
- Targeting Aurora kinases in ovarian Cancer.
- Hormone replacement therapy after treatment of endometrial Cancer.
- Update on aurora kinase inhibitors in gynecologic Malignancies.
- Targeted therapies in gynecologic Cancers.
- Targeted therapies for rare gynaecological Cancers.
- Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian Cancer.
Schools
Jefferson Med CollThos Jefferson Univ
University Sc Hosps
MD Anderson Med Center
Conditions Treated
- Anemia
- Cervical Cancer
- Liver Cancer
- Lung Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
- Medicare MCR
- United Healthcare
Education
-
University of Texas Health Science Center -
Medical University of South Carolina -
Jefferson Medical College
Helpful Reviews
Similar Doctors
|
|
Dr. Shamail Butt, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shagufta N. Naqvi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul G. Corn, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rachel L. Theriault, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan M. Escudier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric Jonasch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Verena M. Hug, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick Hwu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pierre Saintigny, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Philip A. Salem, MD
This Doctor is OpenDoctor Recommended.
|